Assessing cardiovascular risk in hepatitis C: An unmet need-Reference-Cited by-同舟云学术

Assessing cardiovascular risk in hepatitis C: An unmet need

Published:2015 Issue:19 Volume:7 Page:2214
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:en
Short-container-title:WJH

Author:

Ampuero Javier

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference49 articles.

1. World Health Organization. Hepatitis C. [Accessed 2014 Dec] Available from: http://www.euro.who.int/en/what-we-do/health-topics/communicable-diseases/hepatitis.

2. The Oncogenic Role of Hepatitis C Virus

3. Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascular

4. Ampuero J, Gallego-Durán R, Romero-Gómez M. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis. Rev Esp Enferm Dig 2015;107:10-16.

5. Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The inflammatory spectrum of cardiomyopathies;Frontiers in Cardiovascular Medicine;2024-02-23

2. The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infection;Saudi Pharmaceutical Journal;2021-10

3. Hepatitis C: clinical management and debated issues;Minerva Medica;2021-04

4. Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR Study;Clinical and Translational Gastroenterology;2020-08

5. The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid Atherosclerosis;Cardiology in Review;2020-06-18